ON101 Cream

DRUG5 trials

Sponsors

Oneness Biotech Co., Ltd.

Conditions

Chronic Diabetic Foot UlcersDiabetic FootDiabetic Foot UlcerDiabetic Foot UlcersVenous Leg Ulcers (VLU)

Phase 3

Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

CompletedNCT01898923

Oneness Biotech Co., Ltd.Diabetic Foot

Start: 2012-11-23End: 2020-05-11Updated: 2021-04-14

Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

TerminatedNCT04962139

Oneness Biotech Co., Ltd.Chronic Diabetic Foot Ulcers

Start: 2021-07-27End: 2022-11-29Updated: 2025-03-13

Phase 4

A Research Study to Evaluate the Safety and Potential Efficacy of ON101 Cream for the Treatment of Venous Leg Ulcers.

TerminatedNCT05322525

Oneness Biotech Co., Ltd.Venous Leg Ulcers (VLU)

Start: 2021-06-23End: 2023-08-15Updated: 2025-03-12

Unknown Phase

A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs.

CompletedNCT04945161

Oneness Biotech Co., Ltd.Diabetic Foot Ulcers

Start: 2021-02-23End: 2021-12-24Updated: 2023-01-05

Retrospective Record-review Study in Patients Who Had Diabetic Foot Ulcer

CompletedNCT05135130

Oneness Biotech Co., Ltd.Diabetic Foot Ulcer

Start: 2021-10-04End: 2022-01-20Updated: 2026-03-06

Related Papers

100-OR: A Novel Macrophage-Regulation Drug for Treating Diabetic Foot Ulcer—A Phase III MRCT Study and Taiwan Experience

Diabetes2023-06-202 citations

RJX Improves Wound Healing in Diabetic Rats

Frontiers in Endocrinology2022-06-0213 citations

Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers

JAMA Network Open2021-09-03107 citations